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Abstract
Gold nanoparticles (GNPs), have been demonstrated as effective preclinical
radiosensitising agents in a range of cell models and radiation sources. These
studies have also highlighted difficulty in predicted cellular radiobiological
responses mediated by GNPs, based on physical assumptions alone, and therefore
suggest a significant underlying biological component of response. This study aimed
to determine the role of mitochondrial function in GNP radiosensitisation. Using assays
of DNA damage and mitochondrial function through levels of oxidation and loss of
membrane potential, we demonstrate a potential role of mitochondria as a central
biological mechanism of GNP mediated radiosensitisation.
Keywords: Gold nanoparticles; Radiosensitisation; Radiation; Mitochondria;
Oxidative stress
Background
The application of radiobiological principles in clinical oncology aims to describe the
relationship between absorbed dose and the resulting biological responses of tumour
and normal tissues (Hall & Giaccia 2012). Central to the development of novel clinic
approaches is improvement in the differential responses between normal and tumour
tissue at a fixed dose, termed the therapeutic ratio. Improvements in the therapeutic
ratio of radiotherapy have been driven by developments in both radiation biology
and radiation physics which have translated into significant advances in targeted
dose delivery, radiological imaging and biological effectiveness.
Since the pioneering attempts of Denekamp and colleagues in the mid-1970s to
sensitize hypoxic tumour cells (Fowler et al. 1976), much effort has focussed on
increasing tumour cell sensitivity to the biological effects of ionising radiation (Wardman
2007). In the nanotechnology field, gold nanoparticles (GNPs) have been extensively
investigated as radiosensitisers, reviewed by our laboratory (Butterworth et al. 2012);
and have recently shown efficacy under hypoxic conditions (Jain et al. 2014). GNPs
are applicable as radiosensitsers due to their high atomic number (Z = 79) which
results in preferential mass energy absorption compared to soft tissue (Hubbell &
Seltzer 1996). Additionally, GNPs are relatively easy to synthesize in a range of sizes,
can be readily functionalised, and have been shown to passively accumulate in
tumours through the enhance permeability and retention effect (EPR) (Maeda et al.
2000).
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Calculations of X-ray dose enhancement factors based on physical absorption charac-
teristics have predicted enhancements of between 1.2 and 5 depending on the GNP
concentration and beam energy, with the greatest effect predicted at kilovoltage
energies (Cho 2005; McMahon et al. 2008). Despite these predictions radiosensitisation
of cells exposed to GNPs and irradiated with megavoltage energies has been shown
suggesting additional processes in the radiosensitising effect of GNPs (Chithrani et al.
2010; Jain et al. 2011). In addition to possible biological mechanisms, one factor
which may contribute to these effects is localised energy deposition around GNPs.
Following ionisation of gold atoms, large numbers of low-energy electrons are generated
through Auger cascades which deposit their energy at high density within a small
radius around the GNP, leading to high localised doses. These high, inhomogeneous
doses generated in close proximity to the nanoparticle surface are known to have
significantly increased biological effectiveness with analysis of nanoscale dose dis-
tributions around GNPs using the Local Effect Model (McMahon et al. 2011a;
McMahon et al. 2011b) suggesting this may contribute to the observed radiosensitising
effects of GNPs.
Of the wide ranging studies describing the biological effects of GNPs, several have
reported elevated levels of reactive oxygen species for GNPs of differing size, shape
and surface functionalization (Pan et al. 2009; Chompoosor et al. 2010; Li et al. 2010;
Piryazev et al. 2013; Mateo et al. 2014). Comparatively few reports have demonstrated a
role for ROS or the involvement of mitochondria as mechanism of GNP radiosensitisation
(Geng et al. 2011). The current study builds on previous data from our laboratory
demonstrating radiosensitising effects of 1.9 nm Aurovist GNPs at kilovoltage energies
(Butterworth et al. 2010) as a result of significantly elevated levels of DNA damage which
may be a direct result of impaired mitochondrial functional manifested by increased
oxidation and loss of membrane potential.
Materials and methods
Cell culture
All cell lines were obtained from Cancer Research UK. The human breast cancer cell
line, MDA-MB-231 was maintained in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% foetal bovine serum and 50 μg/ml penicillin/streptomycin. The
human prostate cell line, DU-145 was maintained in RPMI-1640 medium with 10%
foetal bovine serum and 50 μg/ml penicillin/streptomycin. The human glioma cell line,
T98G was maintained in EMEM supplemented with 10% foetal bovine serum and
50 μg/ml penicillin/streptomycin.
Gold nanoparticles
1.9 nm AurovistTM particles were purchased from Nanoprobes Inc. (NY, USA) and re-
suspended in sterile water. 1.9 nm AurovistTM are spherical particles with a proprietary
thiol coating (Coulter et al. 2012). Cells were treated at a concentration of 500 μg/ml
for 24 hours unless otherwise indicated. This concentration of 500 μg/ml and time
point of 24 hours was chosen as a result of previous work within the group showing
that these conditions allow for optimal cell uptake of GNPs (Coulter et al. 2012).
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Cell Irradiation
Cells were irradiated with 225 kVp X-rays produced using an X-Rad 225 X-ray generator
(Precision, X-ray Inc, USA). All quoted doses are the absorbed dose from this source
in water.
Clonogenic cell survival assay
Sub-confluent cells were removed from flasks using a solution of 0.25% Trypsin and
1 mM EDTA, they were counted using a Coulter counter and re-seeded into six well
plates at a density of 1.5 x 105 cells per well. Cells were left to attach for 4–6 hours and
treated with gold nanoparticles for 24 hours. Cells were then irradiated, trypsinised and
counted, then seeded into T25 flasks and left to proliferate for 7–9 days. For MDA-
MB-231, DU145 and T98G cell lines 500 cells were seeded per treatment for 0 Gy and
2 Gy doses, 1,000 cells for 4 Gy and 2,000 cells for 8 Gy. MDA-MB-231, DU-145 and
T98G cells had plating efficiencies of approximately 50%. Surviving fraction was calculated
by dividing the number of surviving colonies in the irradiated samples by the number of
surviving colonies in the non-irradiated controls for each treatment. Dose enhancement
factor (DEF) is defined here as the ratio of doses which lead to equal levels of cell survival
with and without GNPs. DEFs can vary with delivered dose, and are quoted with reference
to the dose delivered to cells in the absence of GNPs.
Immunofluorescent microscopy
Cells were seeded onto sterile 16 mm2 coverslips placed in six well plates at a density
of 1 x 105 cells per well. Cells were left to attach for 4–6 hours before treatment. After
incubation with GNPs cells were irradiated with 2 Gy and fixed 1 hour or 24 hours post
irradiation with a 50% acetone/50% methanol solution for 10 minutes. Cells were then
permeabilised with 0.5% Triton X-100 and PBS solution for 10 minutes before being
incubated with a blocking buffer of 0.2% milk, 5% Horse serum, 0.1% Triton X-100 in
PBS for 1 hour at room temperature. Coverslips were then incubated with 53BP1 anti-
body (Novus Biologicals, Colorado, USA) at a dilution of 1:1000 in blocking buffer for
1 hour at room temperature. They were then rinsed three times with washing buffer,
0.1% Triton X-100 in PBS before being incubated with Alexa Fluor 488 Goat anti
Rabbit secondary antibody (Invitrogen Molecular Probes, Oregon, USA) at a dilution of
1:1000 in blocking buffer for one hour at room temperature. Coverslips were rinsed
three times in washing buffer and then mounted onto glass microscope slides with 5 μl of
Vectashield mounting media (Vector Labs Ltd, UK) and sealed with nail varnish. Foci
were viewed and counted manually on a Zeiss Axiovert 200 M fluorescent microscope.
Mitochondrial membrane polarisation measurement
Cells were seeded into 12 well plates at a density of 1 × 105 cells per well and left to
attach for 4–6 hours before treatment. 25 nM Tetramethylrhodamine ethyl ester
perchlorate (TMRE) (Sigma-Aldrich) was added to each well and incubated for
15 minutes at 37°C. Media was then transferred to 15 ml centrifuge tubes and
placed on ice. Cells were detached using 0.25% trypsin and 1 mM EDTA and the cell
solution was then transferred to the corresponding 15 ml tube left on ice. Cells were
then pelleted by centrifugation at 2000 rpm at 4°C for 5 minutes. Media was
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removed and cell pellets were resuspended in 300 μl of PBS and TMRE fluorescence
was analysed immediately using a FACSCalibur flow cytometer with an air-cooled
argon-ion 15 milliwat 488 nm laser and 585 nm detector and CELL-Quest software
(BD biosciences) 1 x 104 cells were analysed per sample.
Mitochondrial oxidation detection
Mitochondrial oxidation was measured using Nonyl-Acridine Orange (NAO) (cat no
A-1372, Molecular Probes, Invitrogen, NY). 1 × 105 cells were seeded into 12 well plates
and left to attach for 4–6 hours before being treated accordingly. At the end of treatment,
media was removed from cells and transferred to 15 ml centrifuge tubes on ice. Cells were
detached using 0.25% Tryspin/1 mM EDTA solution and added to corresponding
tubes containing media. Cells were then pelleted by centrifugation at 2000 rpm at 4°C
for 5 minutes. Media was removed and cell pellets were resuspended in 300 μl of
0.1% BSA-PBS solution containing 25 ng/ml NAO and left to incubate at 37° for
10 minutes. Cells were placed on ice post-incubation and analysed immediately using
FACSCalibur flow cytometer with an air-cooled argon-ion 15 milliwatt 488 nm laser
and 585 nm detector and CELL-Quest software (BD biosciences). 1 × 104 cells were
analysed per sample.
Results
Radiosensitising effects of 1.9 nm GNPs
To assess the efficacy of 1.9 nm GNPs as radiosensitisers, clonogenic cell survival assays
were performed in three cancer cell lines. Cells were treated with 500 μg/ml of AurovistTM
added to the culture medium 24 hours prior to irradiation with 225 kVp X-rays (Figure 1).
GNP concentrations and incubation time were chosen to complement previous studies
from our laboratory (Jain et al. 2011; Coulter et al. 2012). Dose enhancement factors (DEFs)
were calculated as the ratio of doses leading to equal levels of cell survival in the presence
and absence of GNPs. DEFs can vary with delivered dose and are quoted with reference to
the dose delivered to cells in the absence of GNPs. Table 1 summarizes the DEF for each
cell line and gold nanoparticle preparation for 2 Gy, 4 Gy and 8 Gy doses.
Significant radiosensitising effects were observed in both MDA-MB-231 and T98G
cell lines with 1.9 nm GNPs but not DU-145 cells as shown in Figure 1. T98G glioma
cells show the greatest amount of cell death enhancement with a DEF of 1.90 ± 0.22 at
2 Gy with 1.9 nm GNPs. MDA-MB-231 cells also show increased cell kill with GNPs
with a lower DEF of 1.23 ± 0.14 at 2 Gy compared to T98G cells. DU-145 cells show
virtually no change in cell survival across all doses investigated. It should also be noted
that in the T98G cell line, GNP DEFs appear to decrease with increasing dose; at 8 Gy
the DEF decreased to 1.35 ± 0.03, suggesting GNPs are not solely acting as a dose
modifying agent as DEFs would be expected to be uniform across all doses in this case.
GNP induced changes in DNA damage
DNA damage was assessed by imaging and counting immunofluorescently stained
53BP1 foci in cells seeded onto glass coverslips. 53BP1 binds to tumour suppressor
protein p53 and has been shown to accumulate at the sites of DNA damage and is
required for the initiation of DNA repair (Wang et al. 2002). Figure 2 shows levels of
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DNA damage in MDA-MB-231, DU145 and T98G cells 1 hour and 24 hours after ir-
radiation with and without GNPs. As shown in Figure 2, DNA damage increases
following exposure to GNPs in the absence of radiation across all cell lines with
increases of 30, 45 and 39% observed in MDA-MB-231, DU145 and T98G cells
respectively. Increased levels of DNA damage were also present at 1 and 24 hours
post irradiation with 2 Gy in MDA-MB-231 and DU-145 cells, but not T98G cells
which showed a significant decrease in DNA damage in the presence of GNPs at
24 hours post irradiation. The residual DNA damage present 24 hours post irradiation
with GNPs in MDA-MB-231 and DU145 cells suggests complex damage which hasn’t
been repaired or an inability to repair the damage.
To determine if radiation induced effects were additive to the DNA damage induced
solely by GNPs the percentage variation in DNA damage induced by GNPs was
compared to the percentage increase in DNA damage caused by GNPs and irradiation as
in Figure 3A. In the absence of irradiation, GNP treatment results in a 30% enhancement
of DNA damage foci in MDA-MB-231 cells compared to a 34% enhancement at 1 hour
post irradiation suggesting the observed enhancement post irradiation is due to an
Figure 1 Radiation dose response curves for (A) MDA-MB-231, (B) DU145 and (C) T98G cells treated
with 500 μg/ml of 1.9 nm gold nanoparticles (GNPs) 24 hours prior to irradiation with 225 kVp x-rays.
Experiments were performed at least three times in triplicate, means are presented ± standard error of the mean.
Table 1 Summary of dose enhancement factors (DEF) ± uncertainties for the cell lines
investigated when irradiated at 2 Gy, 4 Gy and 8 Gy after treatment with 1.9 nm gold
nanoparticles
MDA-MB-231 DU145 T98G
2 Gy 1.23 ± 0.14 1.01 ± 0.20 1.90 ± 0.22
4 Gy 1.20 ± 0.06 1.06 ± 0.10 1.57 ± 0.08
8 Gy 1.17 ± 0.02 1.1 ± 0.04 1.35 ± 0.03
DEF is defined here as the ratio of doses which lead to equal levels of cell survival with and without GNPs. DEFs can vary
with delivered dose, and are quoted with reference to the dose delivered to cells in the absence of GNPs.
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extension of the original damage caused by GNP treatment and not an additive effect
of radiation exposure.
Furthermore, the distribution of foci numbers per cell was analysed in Figure 3B in
order to determine if there was an overall increase in the levels of DNA damage across
the population or if a subset of the population with a significant increase in DNA
damage was driving the increase in average foci number. MDA-MB-231 and DU-145
cells both show a slight shift in a population subset with a peak of increased DNA
damage when cells are treated with GNPs, which is further amplified with irradiation.
T98G cells also show a slight peak shift towards additional damage upon nanoparticle
treatment, but not in the presence of radiation.
GNP induced changes in mitochondrial membrane polarisation
Changes in mitochondrial membrane polarisation were measured by flow cytometry
analysis following 24 hours exposure to GNPs with and without exposure to a single
dose of 2 Gy (Figure 4). In irradiated samples, depolarisation was measured 1 and 4 hours
Figure 2 DNA damage analysis measured by immunofluorescent staining of 53BP1 foci for (A)
MDA-MB-231, (B) DU145 and (C) T98G cells treated with 500 μg/ml of 1.9 nm gold nanoparticles
(GNPs), 24 hours prior to irradiation with 225 kVp X-rays at a dose of 2 Gy. Cells were fixed, stained
and foci scored at 1 hour and 24 hours post irradiation. For each of the experimental conditions, foci were
scored in > 50 nuclei. Experiments were performed at least three times in triplicate, means are presented ±
standard error of the mean. Statistical analysis was performed using a paired t-test with significant differences
assumed at the level of *p = ≤ 0.05.
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post irradiation. In unirradiated cells, GNPs alone significantly reduced mitochondrial
membrane polarisation relative to controls across all cell lines with decreases of 50%, 55%
and 25% in TMRE fluorescence in MDA-MB-231, DU-145 and T98G cells respectively.
MDA-MB-231 and T98G cells both displayed an increase in mitochondrial membrane
polarisation of 30% and 25% respectively, 1 hour post irradiation when exposed to GNP
in combination with 2 Gy irradiation, which was significant in MDA-MB-231 cells,
however, this coincided with an increase in membrane polarisation upon irradiation
alone. At 4 hours post irradiation with GNPs membrane polarisation had returned to
the same level as non-irradiated GNP treated samples across all cell lines.
GNP induced changes in mitochondrial membrane oxidation
Mitochondrial oxidation was measured by NAO fluorescent flow cytometry analysis 1
and 4 hours post 2 Gy irradiation following 24 hour exposure to GNPs (Figure 5). Similar
Figure 3 Percentage change in DNA damage and distribution of damage foci per cells treated with
500 μg/ml of 1.9 nm gold nanoparticles (GNPs) 24 hours prior to irradiation with 225 kVp x-rays at a
dose of 2 Gy. Cells were fixed, stained and foci scored at 1 hour and 24 hours post irradiation. (A) Percentage
change in average foci per cell for GNP exposed cells compared to control cells of the same condition
calculated for both irradiated and non-irradiated cells. (B) Distributions of 53BP1 foci in cells (i) MDA-MB-231,
(ii) DU145 and (iii) T98G cells. All figures are representations of foci data presented in Figure 2.
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reductions in fluorescence of NAO indicating mitochondrial oxidation were observed as
seen previously with 40%, 45% and 25% reduction in fluorescence after GNP exposure
in MDA-MB-231, DU145 and T98Gs respectively. These levels of oxidation remained
consistent at both time points following irradiation indicating no significant change
in mitochondrial oxidation.
Figure 4 Mitochondrial membrane polarisation after GNP and irradiation. Mitochondrial membrane
polarisation was measured by TMRE flow cytometry and made relative to untreated control after cells were
treated with 1.9 nm GNPs and/or 2 Gy irradiation. Means are presented ± standard error of the mean. n = 5.
Significance was measured by paired t tests against controls. A line between two bars with asterix denotes
significant differences between two conditions. *p = ≤0.05, **p = ≤0.01, ***p = ≤0.001.
Figure 5 Mitochondrial oxidation after GNP and irradiation. Mitochondrial oxidation was measured by
NAO flow cytometry and made relative to untreated control after cells were treated with 1.9 nm GNPs and/or
2 Gy irradiation. Means are presented ± standard error of the mean. n = 3. Significance was measured by paired
t tests against controls. *p = ≤0.05.
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Discussion
Classical approaches used to radiosensitise cells have included radiation induced activation
of prodrugs, suppression of intracellular thiols, inhibition of DNA repair and oxygen
mimetics (Wardman 2007). Nitrobenzenes, nitrofurans and nitroimidazoles have been
used to radiosensitise hypoxic cells with their radiosensiting ability attributed to their
high electron affinity (Adams & Cooke 1969). These compounds are generally activated
by reduction in hypoxic conditions and work in a similar way to oxygen by causing DNA
double strand breaks in the presence of irradiation as a result of the fixation of free radical
damage (Katz et al. 2009). Despite extensive preclinical research and promising evidence,
hypoxic radiosensitisers have failed to reach their full potential in the clinic (Bischoff
et al. 2009).
The concept of targeting repair DNA stems from the central dogma underpinning
radiotherapy, which is to induce complex DNA damage lesions which are difficult to
repair resulting in cell death. Cisplatin and 5-fluorouracil exemplify radiosensitisers in
clinical use, acting by interfering with DNA synthesis, however, their precise mechanism
of action in radiosensitisation is not fully understood (Katz et al. 2009).
Similarly, whilst GNPs have been demonstrated as effective radiosensitisers at a range
of photon energies, there is insufficient explanation of their underlying biological
mechanism of action (Butterworth et al. 2012). In this study we further validate previous
reports from our laboratory showing significant radiosensitising effects of GNPs at 225
kVp (Butterworth et al. 2010). Analysis of DNA damage foci distributions from Figure 3B
compared to foci scores in Figures 2 and 3A, shows the increased DNA damage following
treatment with GNPs alone appears to be a result of a small shift in the observed
levels of DNA damage within the whole cell population. In contrast, the increased
levels of DNA damage seen after irradiation with GNPs appeared to be a result of a
cell population subset with greatly amplified levels of DNA damage rather than the
whole population. This is particularly obvious in MDA-MB-231 cells and can be seen
at 1 and 24 hours post irradiation. This could be a result of the induction of oxidative
stress which has previously been observed in our laboratory for the same GNPs
(Butterworth et al. 2010).
To further determine the biological mechanism of GNP mediated radiosensitisation,
this study considered the mitochondria as an extra-nuclear target for GNPs within
the cell. Mitochondria have multiple roles in important cellular functions, including
the production of adenosine triphosphate (ATP), cell signalling, cell growth, cell cycle
progression and cell death (Raimundo 2014). In this study we clearly demonstrate
GNPs to have a significant impact on mitochondrial function, manifested by oxidation
of the mitochondrial membrane protein, cardiolipin and cell specific disruption of
mitochondrial membrane potential. Although these effects could be driven by direct
physical interaction with mitochondrial proteins and enzymes, this study supports an
indirect interaction of GNPs with mitochondria, triggered by whole cell chemical processes
such as oxidative stress. Additional experimental studies are required to further elucidate
the precise mechanism of interaction.
Mitochondrial membrane depolarisation can be caused by the presence of free radicals,
high intracellular calcium concentrations or stress of the endoplasmic reticulum
(Gunter & Pfeiffer 2009; Deniaud et al. 2008). Considering the various reports of GNPs
causing the induction of ROS and specifically the GNPs used in our experiments, it is
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likely that elevated ROS result in mitochondrial depolarisation (Butterworth et al. 2010).
Mitochondria and mitochondrial function can be downstream targets of oxidative
stress which impairs their function, and they themselves can produce reactive oxygen
species and induce oxidative stress in the cell (Zorov et al. 2006). The effect of GNPs
on mitochondrial processes could be a direct contributor to the DNA damage seen
upon exposure to gold nanoparticles, as mitochondria have been shown to play a role
in the induction of DNA damage (Tartier et al. 2007).
Oxidative stress and mitochondrial depolarisation are often significant cellular events
preceding the induction of cell death, particularly by apoptosis. A key step in the
initiation of the intrinsic apoptotic pathway is the oxidation of cardiolipin, which is
assessed in this study by measuring the binding of the fluorescent compound NAO
through flow cytometry. The oxidation of cardiolipin releases cytochrome c into the
cytosol initiating apoptosis; this has been described as critical point in apoptotic
signalling beyond which the cell is terminally committed to die (Jiang et al. 2008).
Significant loss of fluorescence from nonyl-acridine orange in both MDA-MB-231
and T98G cells indicates oxidation of cardiolipin. Some loss of NAO fluorescence was
also observed in DU-145 cells however, the level was not statistically significant.
In order to test the hypothesis that mitochondrial responses are initiated by GNPs
and may predispose cells to radiosensitisation, it was important to confirm that these
responses were not altered with the addition of irradiation. Figures 4 and 5 show no
additional change in response to radiation in combination with GNP compared to
GNPs alone, similar to the DNA damage data in Figure 2. Comparable to mitochondrial
membrane polarisation, levels of cardiolipin oxidation remain steady post irradiation.
However, the lack of change in the levels of mitochondrial membrane polarisation
and cardiolipin post irradiation further emphasises the significance of the cellular
events prior to irradiation in GNP radiosensitisation. As summarised in Figure 6, we
Figure 6 Schematic representation of gold nanoparticle (GNP) radiosensitisation through
mitochondrial function.
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propose the mitochondria as having a central role in biological response to GNPs
alone and in combination with ionising radiation.
Conclusions
1.9 nm gold nanoparticles are effective radiosensitisers showing significant decreases
cell survival. In the absence of ionising radiation, GNPs have effects on DNA damage
levels as well as mitochondrial function. These cell specific responses to GNPs have the
potential to provide a biological mechanism for the sensitisation of cells to the effects
of ionising radiation. This mitochondria mediated enhancement in cell death may in
part explain the disparities between predicted physical dose enhancement and observed
biological effect.
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